The New York Times reported last week that Legend Biotech has developed a potential cure for the incurable and brutally painful disease known as multiple myeloma.
It raises a question: would readers accept tariffs on Legend’s drugs if the corporation weren’t based in Somerset, NJ? Clown question. Cancer in its various forms takes the lives of far too many way too early, so let’s not tax the import of what elongates lives, right?
Read Full Article »
